drugset / Trial / NCT01702974

Immune Reconstitution in HIV Disease (IREHIV)

NCT01702974

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim with this study is to provide immunotherapy with vitamin D and phenylbutyrate to treatment-naive HIV infected patients to induce important antimicrobial defence mechanisms and decreased inflammation.

Timeline

Start
2012-09
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 5000 iu
Comparator Sodium Phenylbutyrate Small molecule 500 mg